Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Regulus Therapeutics (NQ: RGLS )

1.430 -0.070 (-4.67%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 261,914
Open 1.520
Bid (Size) 1.410 (1)
Ask (Size) 1.510 (1)
Prev. Close 1.500
Today's Range 1.401 - 1.520
52wk Range 1.080 - 3.790
Shares Outstanding 87,040,335
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q2 2024
RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga

Performance

YTD
+9.16%
+9.16%
1 Month
-8.92%
-8.92%
3 Month
-9.49%
-9.49%
6 Month
-28.86%
-28.86%
1 Year
+2.14%
+2.14%

More News

Read More
What's Going On With Regulus Therapeutics Stock Monday?
Via Benzinga
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q1 2024
Via InvestorPlace
The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Analyst Expectations for Regulus Therapeutics's Future
Via Benzinga
Expert Ratings for Regulus Therapeutics
Via Benzinga
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q4 2023
Via InvestorPlace
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
Via AB Newswire
Gold Down Over 1%; ClearOne Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Regulus Therapeutics Inc. (NASDAQ: RGLS) is One of Tuesday Morning’s Most Active Stocks
Via Investor Brand Network
Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is Kidney Disease-Focused Regulus Therapeutics Stock Trading Higher On Tuesday?
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Regulus Therapeutics Releases Early Data From Of Investigational For Rare Type Of Kidney Disease
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.